Excess body fat particularly visceral abdominal fat is associated with lower testosterone levels, increased estrogen, and worsened insulin sensitivity
This means the highest supplement priority of all three medications
As of June 2026, cagrilintide is not FDA-approved in any form
While the precise mechanism behind these headaches is not entirely clear, it is thought to be connected to the medications influence on blood vessels and neural pathways
[114] Novo Nordisk appealed the ruling and the decision was overturned by the Supreme People's Court
Significant improvements were also observed in fibrosis markers, including FIB-4, CAP, and LSM, supporting the potential for broader clinical use of semaglutide in NAFLD patients with type 2 diabetes and obesity